EMMA · All filings · Read this filing

What changed 10-Q

Item 5. Other Information

2021-09-01 compared with 2021-09-01 · 11 added, 2 removed, 26 unchanged (33% of the section changed)

2 unchanged sentences

Exhibit Description

Promissory Note dated April 24, 2021 issued by registrant to Eastwind, Ltd.

Promissory Note dated May 26, 2021 issued by registrant to Shigeru Matsuda

Promissory Note dated January 20, 2021 issued by registrant to Soomi Niihara

Promissory Note dated February 17, 2021 issued by registrant to Shigeru Matsuda

Securities Purchase Agreement dated as of February 8, 2021 among Emmaus Life Sciences, Inc.

and the "Purchasers" Thereunder

February 16, 2021

Transfer Restriction and Voting Agreement dated February 8, 2021 between Emmaus Life Sciences, Inc.

and the “Purchaser” Thereunder

February 16, 2021

Purchase and Sale Agreement dated , 2021 between Emmaus Medical, Inc.

and Prestige Capital Finance, LLC

February 22, 2021

Certification of Chief Executive Officer pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

22 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.